Alzheimer's disease is a progressive neurodegenerative disease most often associated with
memory deficits and cognitive decline, although less common clinical presentations are …

Alzheimer disease (AD), the most common form of dementia globally, classically defined a
clinicopathological entity, is a heterogenous disorder with various pathobiological subtypes …

Alzheimer's disease (AD) is a complex neurodegenerative dementing illness. Over the past
few years, however, remarkable advances have taken place in understanding both the …

Alzheimer disease (AD) is a neurodegenerative disorder characterized pathologically by the
presence of neurofibrillary tangles and amyloid beta (Aβ) plaques in the brain. The disease …

Epidemiological and molecular studies suggest that Alzheimer's disease (AD) has multiple
etiologies including genetic mutations, genetic variations affecting susceptibility and …

The unequivocal diagnosis of Alzheimer's disease (AD) rests on histopathological evidence
at brain autopsy or biopsy. The morphology of AD includes cerebral atrophy, deposition of …

The field of Alzheimer's disease (AD) research has grown exponentially over the past few
decades, especially since the isolation and identification of amyloid-β from postmortem …

The number of people with dementia worldwide is predicted to increase to 131.5 million by
2050. When studying dementia, understanding the basis of the neuropathological …

Establishing the in vivo diagnosis of Alzheimer's disease (AD) or other dementias relies on
clinical criteria; however, the accuracy of these criteria can be limited. The diagnostic …

Alzheimer disease is a complex neurodegenerative dementing illness. It has become a
major public health problem because of its increasing prevalence, long duration, high cost of …